Press Releases September 3, 2026 11:16 AM

Progyny, Inc. to Present at the Wells Fargo Healthcare Conference

Progyny CFO to Present at Wells Fargo Annual Healthcare Conference

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
PGNY

Progyny, Inc., a leading women's health and family building solutions provider, announced that CFO Mark Livingston will present at the Wells Fargo 21st Annual Healthcare Conference. The company highlights its comprehensive fertility and women's health benefits solutions designed to optimize clinical outcomes and reduce healthcare costs.

Progyny, Inc. to Present at the Wells Fargo Healthcare Conference
PGNY
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Progyny is a prominent player in women's health and family building solutions with a focus on fertility benefits and digital support tools.
  • The CFO presentation at a significant healthcare investment conference signifies ongoing investor engagement and company transparency.
  • Progyny offers comprehensive support services including concierge, coaching, and access to a premier network of specialists, aiming to improve clinical outcomes while lowering healthcare costs.

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its Chief Financial Officer Mark Livingston will present at the Wells Fargo 21st Annual Healthcare Conference in Boston, MA on Tuesday, September 8, 2026, at 11:00 a.m. ET.

Live audiocasts and replays of the webcasted session will be available in the Events and Presentations section of Progyny’s investor relations website at http://investors.progyny.com.

About Progyny

Progyny (Nasdaq: PGNY) is a global leader in women's health and family building solutions, trusted by the nation's leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients, and physicians.

Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.

Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, INC. 5000, INC. Power Partners and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.

For Further Information, Please Contact:

Investors:
James Hart
investors@progyny.com

Media:
Alexis Ford
media@progyny.com


Risks

  • Market competition within the women's health and fertility benefits sector may impact growth potential.
  • Dependence on employer and health plan adoption of Progyny's benefit solutions could influence financial performance.
  • Healthcare cost pressures and regulatory changes could affect the company's operational environment and profitability.

More from Press Releases

eSIM Plans Launch on the BOSS Revolution App, Offering High-Speed Connectivity in 190+ Countries Sep 3, 2026 Cricut® Introduces Cricut Maker® 5, Its Most Versatile Smart Cutting Machine Yet Sep 3, 2026 Vishay Intertechnology’s Thin Film High Frequency Chip Resistors Deliver More Power in Less Space, Without Need for a Heatsink Sep 3, 2026 Final Opportunity to Own a New Luxury Home in Toll Brothers at Tesoro Highlands - Alta Monte Collection in Valencia, California Sep 3, 2026 Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States Sep 3, 2026